Pediatric Drug Labeling and Imperfect Information

I first became aware of bioethics in the spring of 1980. I had spent a thirty-six-hour shift shadowing a medical resident, and I was struck that many of the resident's decisions had ethical dimensions. The next day, I came across the Hastings Center Report, and I realized I wanted to explore et...

全面介紹

Saved in:  
書目詳細資料
主要作者: Wilfond, Benjamin S. (Author)
格式: 電子 Article
語言:English
Check availability: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
出版: 2020
In: The Hastings Center report
Year: 2020, 卷: 50, 發布: 1, Pages: 3
在線閱讀: Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000naa a22000002c 4500
001 1937528839
003 DE-627
005 20251002055613.0
007 cr uuu---uuuuu
008 251002s2020 xx |||||o 00| ||eng c
024 7 |a 10.1002/hast.1074  |2 doi 
035 |a (DE-627)1937528839 
035 |a (DE-599)KXP1937528839 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Wilfond, Benjamin S.  |e VerfasserIn  |4 aut 
109 |a Wilfond, Benjamin S.  |a Wilfond, Benjamin 
245 1 0 |a Pediatric Drug Labeling and Imperfect Information 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a I first became aware of bioethics in the spring of 1980. I had spent a thirty-six-hour shift shadowing a medical resident, and I was struck that many of the resident's decisions had ethical dimensions. The next day, I came across the Hastings Center Report, and I realized I wanted to explore ethical issues I found implicit in clinical care, even though I still wanted to become a pediatrician. In September 2019, when I attended my first meeting of the U.S. Food and Drug Administration's Pediatric Advisory Committee, as a pediatric pulmonologist, I had the same sense of awe and curiosity that I had forty years ago. What had appeared initially as somewhat technical decisions about the regulation of drug labeling was suffused with ethical questions. The committee was asked to discuss possible changes to the labeling of two previously approved drugs. 
773 0 8 |i Enthalten in  |a Hastings Center  |t The Hastings Center report  |d Malden, Mass. : Wiley, 1971  |g 50(2020), 1, Seite 3  |h Online-Ressource  |w (DE-627)341346551  |w (DE-600)2067369-3  |w (DE-576)258761822  |x 1552-146X  |7 nnas 
773 1 8 |g volume:50  |g year:2020  |g number:1  |g pages:3 
856 |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hast.1074  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via free article)] 
856 4 0 |u https://doi.org/10.1002/hast.1074  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/hast.1074  |x Verlag  |z kostenfrei  |3 Volltext 
912 |a NOMM 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4779655005 
LOK |0 003 DE-627 
LOK |0 004 1937528839 
LOK |0 005 20251002055613 
LOK |0 008 251002||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2025-09-26#57442825088775460A4A93CD63BB7E99D43BE7E4 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixrk  |a ixzs  |a zota  |a tiep 
OAS |a 1 
ORI |a TA-MARC-ixtheoa001.raw